@article{fc16885e01c74c96bc793c97c2f7c011,
title = "Editorial on Pregnancy and the SARS-CoV-2 pandemic",
abstract = "This is an editorial updating evidence about COVID-19 in pregnancy. We focus on whether pregnant women are at increased risk of severe COVID-19, whether the pandemic has impacted pregnancy outcomes, and advances in our knowledge of underlying mechanisms, new treatments and vaccinations.",
keywords = "COVID-19, Female, Humans, Pandemics, Pregnancy, Pregnancy Complications, Infectious/epidemiology, SARS-CoV-2",
author = "Reynolds, {Rebecca M} and Stock, {Sarah J E} and Denison, {Fiona C} and Maybin, {Jacqueline A} and Critchley, {Hilary O.D.}",
note = "Funding Information: H. O. D. Critchley has clinical research support for laboratory consumables and staff from Bayer AG (paid to Institution) and provides consultancy advice (but with no personal remuneration) for Bayer AG, PregLem SA, Gedeon Richter, Vifor Pharma UK, AbbVie, and Myovant Sciences. H. O. D. Critchley receives royalties from UpToDate for an article on abnormal uterine bleeding. S. J. Stock has received research grants paid to the institution from Wellcome Trust, Scottish Chief Scientist Office, National Institute of Healthcare Research, and Tommys during the course of this study. No conflicts of interest, financial or otherwise, are declared by any of the other authors. Funding Information: We acknowledge Medical Research Council Center for Reproductive Health Grant MR/N022556/1 and the support of the British Heart Foundation (RE/18/5/34216) and Tommys. S. J. Stock and J. A. Maybin are supported by Wellcome Trust Clinical Career Development Fellowships 209560/Z/17/Z and 209589/Z/17/Z, respectively.",
year = "2022",
month = jul,
day = "1",
doi = "10.1152/physrev.00003.2022",
language = "English",
volume = "102",
pages = "1385--1391",
journal = "Physiological reviews",
issn = "0031-9333",
publisher = "American Physiological Society",
number = "3",
}